Financials

People

Activity

Global Life Science Ventures

Company

Investment-firm

Financing round

General

About Company
Global Life Science Ventures is a venture capital firm that focuses on early-stage investments in the life sciences industry.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1996

Number of employees

IPO status

Private

Description

Founded in 1996 in Germany, Global Life Science Ventures primarily invested in medical device and biopharmaceutical startups, many of which were spun out of universities and scientific institutions. While the firm had offices in Germany and Switzerland, it initially sought investments in the United States life sciences market. It raised a second fund in 2002 to expand its investments in Europe. The firm closed in 2015 after liquidating its assets.
Similar Companies
1000
Joint Polish Investment Fund

Joint Polish Investment Fund

Joint Polish Investment Fund (JPIF) invests in early and mid-stage Life Science companies in Central and Eastern Europe.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Warsaw, Poland

count Of Investments

8

count Of Exists

2
Inveni Capital

Inveni Capital

Inveni Capital is a venture capital management company focused on investing in early to growth stage life sciences companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

Helsinki, Finland

count Of Investments

5
Oxford Bioscience Partners

Oxford Bioscience Partners

Oxford Bioscience Partners is a venture capital firm that invests in emerging life sciences and healthcare companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Life Science

Location

Boston, MA, USA

count Of Investments

92

count Of Exists

36
Phase4 Partners

Phase4 Partners

Phase4 Partners: European VC firm investing in life science with innovative options for pharma investors.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Life Science, Venture Capital

Location

London, UK

count Of Investments

4

count Of Exists

1

Financials

Investments
24
Date 
name 
Lead 
type 
Raised 
Binx Health

Binx Health

Binx Health is revolutionizing healthcare by providing on-demand testing solutions where people need them most.

Sector

Health Care Providers

Subsector

Health Care Services

Location

Boston, MA, USA

total rounds

10

total raised

$286.74M
Binx Health

Binx Health

Binx Health is revolutionizing healthcare by providing on-demand testing solutions where people need them most.

Sector

Health Care Providers

Subsector

Health Care Services

Location

Boston, MA, USA

total rounds

10

total raised

$286.74M
Santaris Pharma

Santaris Pharma

Santaris Pharma is a biopharmaceutical company focused on developing RNA-targeted therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

2970 Hørsholm, Denmark

total rounds

3

total raised

$90.21M
Co-Investors
Exits
11
Coley Pharmaceutical Group

Coley Pharmaceutical Group

Coley Pharma develops therapeutics to boost immune system against cancer, asthma, allergies, and autoimmune disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Wellesley Hills, Wellesley, MA 02481, USA

total rounds

7

total raised

$85.1M
Coapt Systems

Coapt Systems

Coapt Systems develops bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Palo Alto, CA, USA

total rounds

6

total raised

$58.03M
CareX SA

CareX SA

CareX SA is a biopharmaceutical company focused on developing innovative treatments for metabolic and immune system disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

67400 Illkirch-Graffenstaden, France

total rounds

1

total raised

$32M

People

Employee Profiles
6

Brad Van Pelt

Chief Executive Officer

Hans Kupper

Hans Kupper

Partner

Peter Reinisch

Peter Reinisch

Partner

Holger Reithinger

Holger Reithinger

Principal and Partner

Bert van Toor

Investment Manager

Activity

Recent News
0